Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Doan

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Biorxiv : the Preprint Server for Biology|December 23, 2024
Chemical perturbations impacting histone acetylation govern colorectal cancer differentiationPornlada Likasitwatanakul, Zhixin Li, Paul Doan, et al.
BJU International|August 5, 2024
Irreversible electroporation of localised prostate cancer downregulates immune suppression and induces systemic anti-tumour T-cell activation - IRE-IMMUNO studyBart Geboers, Matthijs J Scheltema, Jason Jung, et al.
BJU International|October 20, 2023
Prostate-specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapyBart Geboers, Dennie Meijer, William Counter, et al.
European Urology Focus|May 16, 2022
Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Irreversible Electroporation-A Multicenter Validation StudyBart Geboers, William Gondoputro, James E Thompson, et al.
European Urology Oncology|July 18, 2024
Has Active Surveillance for Prostate Cancer Become Safer? Lessons Learned from a Global Clinical RegistryChris Bangma, Paul Doan, Lin Zhu, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Biorxiv : the Preprint Server for Biology|December 23, 2024
Chemical perturbations impacting histone acetylation govern colorectal cancer differentiationPornlada Likasitwatanakul, Zhixin Li, Paul Doan, et al.
BJU International|August 5, 2024
Irreversible electroporation of localised prostate cancer downregulates immune suppression and induces systemic anti-tumour T-cell activation - IRE-IMMUNO studyBart Geboers, Matthijs J Scheltema, Jason Jung, et al.
BJU International|October 20, 2023
Prostate-specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapyBart Geboers, Dennie Meijer, William Counter, et al.
European Urology Focus|May 16, 2022
Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Irreversible Electroporation-A Multicenter Validation StudyBart Geboers, William Gondoputro, James E Thompson, et al.
European Urology Oncology|July 18, 2024
Has Active Surveillance for Prostate Cancer Become Safer? Lessons Learned from a Global Clinical RegistryChris Bangma, Paul Doan, Lin Zhu, et al.
Pageof 3